Celltrion
068270.KS
$103.01
Share price
1.90%
Change (1 day)
-24.28%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Market capitalization of Celltrion (068270.KS)
Market cap: $14.54 Billion
As of October 2023 Celltrion has a market cap of $14.54 Billion. This makes Celltrion the world's 1101th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Celltrion from 2007 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $14.54 B | -19.76% |
| 2022 | $18.13 B | -21.81% |
| 2021 | $23.18 B | -48.58% |
| 2020 | $45.09 B | 126.46% |
| 2019 | $19.91 B | -19.83% |
| 2018 | $24.83 B | -3.51% |
| 2017 | $25.74 B | 136.78% |
| 2016 | $10.87 B | 34.5% |
| 2015 | $8.08 B | 123.17% |
| 2014 | $3.62 B | 1.53% |
| 2013 | $3.56 B | -17.91% |
| 2012 | $4.34 B | 19% |
| 2011 | $3.65 B | 5.92% |
| 2010 | $3.44 B | 161.41% |
| 2009 | $1.31 B | 63.51% |
| 2008 | $0.80 B | 4217.29% |
| 2007 | $18.68 M |
End of Day market cap according to different sources
On Sep 30th, 2023 the market cap of Celltrion was reported to be:
